Articles

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years

Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Center of Clinical Trials, University Medical Center Freiburg, Germany
Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Pathology Department, University of Freiburg, Germany
Department of Medical Biometry and Statistics (IMBI), University of Freiburg, Germany
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Vol. 100 No. 10 (2015): October, 2015 https://doi.org/10.3324/haematol.2015.127548